Solara Active Pharma Share Price in Focus as TPG Growth Trims 0.62% Stake for Rs 17.19 Crore

TPG Growth IV SF Pte sells 3 lakh Solara Active Pharma shares, a 0.62% stake, for Rs 17.19 crore at Rs 573.20 apiece. TPG held 2.61% as of March 2026. Stock trades higher near Rs 579.

The Solara Active Pharma share price is in focus on Monday, 13 July 2026, after private equity investor TPG Growth IV SF Pte sold 3 lakh shares of the active pharmaceutical ingredients maker, representing a 0.62 percent stake, for Rs 17.19 crore. The transaction was executed at Rs 573.20 per share through the open market.

As of March 2026, TPG Growth held a 2.61 percent stake in Solara Active Pharma Sciences, so the fund retains close to 2 percent even after this sale. Interestingly, the Solara Active Pharma share price traded higher despite the supply, quoting at Rs 579.05 on the NSE, up 1.78 percent from its previous close of Rs 568.90, on a day the broader market fell sharply.

Click Here – Get Free Investment Predictions

Solara Active Pharma Share Price: TPG Deal Details

The stake trim is part of a familiar pattern of private equity investors gradually monetising listed positions. The table below summarises the transaction details relevant for anyone tracking the Solara Active Pharma share price.

The sale price of Rs 573.20 was at a modest premium to Friday’s close of Rs 568.90, which suggests the block found buyers willing to pay up rather than demanding a discount. That is generally a healthy sign for near-term sentiment in the counter. Blocks executed above the prevailing market price usually indicate that the buyer, often an institution, has conviction in the medium-term trajectory of the Solara Active Pharma share price rather than a purely opportunistic interest.

Why the TPG Stake Sale Matters for the Solara Active Pharma Share Price

1. Private Equity Monetisation, Not a Verdict on the Business

Private equity funds like TPG Growth work on defined fund cycles and routinely trim listed holdings as funds age. A partial exit of 0.62 percent, with close to 2 percent still retained, reads more like calendar-driven monetisation than a negative call on the company’s prospects.

2. API Sector Tailwinds Remain Intact

Solara Active Pharma is a pure-play API manufacturer, and the sector continues to benefit from global supply chain diversification away from China. Pricing stability in key molecules and improving capacity utilisation have supported the recovery narrative in the stock over recent quarters, and several domestic funds have added API names to their portfolios on this theme. Any commentary from the management on new molecule launches and regulatory approvals would add further support to the Solara Active Pharma share price narrative.

3. Absorption of Supply on a Weak Market Day

The 1.78 percent rise in the stock on a day the Sensex crashed over 700 points is a strong relative performance. When a counter absorbs institutional selling and still closes higher against a falling market, it typically signals accumulation by other institutional or informed buyers.

Get Pharma Stock Recommendations from a SEBI-Registered Investment Advisor

What Should Investors Watch in the Solara Active Pharma Share Price Now

The primary monitorable is TPG Growth’s remaining holding of close to 2 percent. Further block deals cannot be ruled out, and the September 2026 shareholding pattern will confirm the fund’s direction. On the fundamentals side, investors should track Q1 FY27 results for API volume growth, gross margin trends, and progress on debt reduction.

The rights issue-related instruments of the company also trade separately, so investors should be careful to distinguish the fully paid shares from partly paid instruments while placing orders. Any sustained move in the Solara Active Pharma share price above the Rs 580 to Rs 585 zone would signal that the market has fully digested the TPG supply.

Download the Univest iOS App or Univest Android App to track the Solara Active Pharma share price live and get daily stock recommendations.

Conclusion

TPG Growth’s sale of 3 lakh shares for Rs 17.19 crore trims its stake in the API maker from 2.61 percent to close to 2 percent, yet the Solara Active Pharma share price rose 1.78 percent to Rs 579.05 against a crashing market. The premium pricing of the block and the positive reaction suggest demand for the counter remains healthy. Investors should track the fund’s residual stake and quarterly performance, and consult a SEBI-registered advisor before taking fresh positions.

Frequently Asked Questions FAQs

Why is the Solara Active Pharma share price in news today?

Ans. The Solara Active Pharma share price is in news because TPG Growth IV SF Pte sold 3 lakh shares, a 0.62 percent stake, for Rs 17.19 crore at Rs 573.20 per share through the open market.

How much stake does TPG Growth hold in Solara Active Pharma?

Ans. TPG Growth held a 2.61 percent stake as of March 2026, and after selling 0.62 percent it retains close to 2 percent in the company.

At what price did TPG Growth sell Solara Active Pharma shares?

Ans. TPG Growth sold the shares at Rs 573.20 per share, which was at a modest premium to the previous closing price of Rs 568.90.

How did the Solara Active Pharma share price react to the stake sale?

Ans. The Solara Active Pharma share price rose 1.78 percent to Rs 579.05 on the NSE, outperforming a market in which the Sensex crashed over 700 points.

What does Solara Active Pharma do?

Ans. Solara Active Pharma Sciences is a pure-play active pharmaceutical ingredients, or API, manufacturer that supplies key molecules to global and domestic formulation companies.

Should investors buy Solara Active Pharma after the TPG stake sale?

Ans. The premium block pricing and positive price reaction are encouraging signs, but investors should track the fund’s remaining stake and quarterly results, and consult a SEBI-registered investment advisor before buying.